This series of five CME-accredited, 30-minute webcasts reviews updates in cancer management presented at the Duke Cancer Review conference. Expert faculty discuss current matters in hematologic and thoracic malignancies, renal cell carcinoma, breast cancer, and brain metastases.
Recent Advances in the Treatment of Hematologic Malignancies
Faculty: Harry P. Erba, MD, PhD; Matthew McKinney, MD
Review the effectiveness of novel treatment strategies, specifically CAR T-cell therapy for relapsed and refractory diffuse large B-cell lymphoma and FLT3-targeted treatment in acute myeloid leukemia.
Advances in the Treatment of Renal Cell Carcinoma
Faculty: Joseph K. Salama, MD; Tian Zhang, MD
Which patients might benefit from cytoreductive nephrectomy? Identify appropriate patients and review recent treatment advances for renal cell carcinoma.
Advances in Breast Cancer
Faculty: Rachel Blitzblau, MD, PhD; Jeremy Force, DO; Jennifer K. Plichta, MD, MS
Explore updates in breast cancer management, including the latest surgical techniques, the use of genomic medicine in HR+/HER2- early stage breast cancer, and radiotherapy fractionation for early stage breast cancer.
Advances in the Management of Brain Metastases
Faculty: Peter E. Fecci, MD, PhD; John Kirkpatrick, MD, PhD; April K.S. Salama, MD
Expert faculty discuss the current understanding of systemic therapy, advances in radiation therapy, and surgical improvements for brain metastasis.
Recent Therapeutic Advances for Thoracic Malignancies
Faculty: Christopher Kelsey, MD; Jacob Klapper, MD; Thomas Eldridge Stinchcombe, MD
Review the role of surgery and radiotherapy in treating patients with small cell and non–small cell lung cancer in the era of immunotherapy.
Find more complimentary CME activities, practice management tips, case studies, and image quizzes at physicians.dukehealth.org
. Plus, sign up
for the bi-weekly Clinical Practice Today e-Publication.